某种肠道细菌
糖尿病
疾病
代谢性疾病
生物
肥胖
代谢综合征
医学
2型糖尿病
生物信息学
药理学
内科学
免疫学
肠道菌群
内分泌学
作者
Huifang Niu,Minfeng Zhou,Daniel Zogona,Zheng Xing,Ting Wu,Rui Chen,Dandan Cui,Fengxia Liang,Xiaoyun Xu
标识
DOI:10.3389/fimmu.2024.1370658
摘要
Metabolic diseases are comprehensive disease based on obesity. Numerous cumulative studies have shown a certain correlation between the fluctuating abundance of Akkermansia muciniphila and the occurrence of metabolic diseases. A. muciniphila , a potential probiotic candidate colonized in the human intestinal mucus layer, and its derivatives have various physiological functions, including treating metabolic disorders and maintaining human health. This review systematically explicates the abundance change rules of A. muciniphila in metabolic diseases. It also details the high efficacy and specific molecules mechanism of A. muciniphila and its derivatives in treating obesity, type 2 diabetes mellitus, cardiovascular disease, and non-alcoholic fatty liver disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI